SDC1 and melanoma: Previously, we showed that LLC cells have high expression of SDC1 and CASP11, with strong susceptibility to SCGB3A2-induced anti-tumor activity, whereas B16F10 melanoma cells have very little expression of SDC1 and CASP11, and no susceptibility to SCGB3A217.